Chapter 4. Scientific, Technical and Economic Aspects of Vaccine Research and Development

  1. Dr. Oliver Kayser,
  2. Prof. Dr. Rainer H. Müller
  1. Dr. Jens-Peter Gregersen

Published Online: 28 JAN 2005

DOI: 10.1002/3527602410.ch4

Pharmaceutical Biotechnology: Drug Discovery and Clinical Applications

Pharmaceutical Biotechnology: Drug Discovery and Clinical Applications

How to Cite

Gregersen, J.-P. (2005) Scientific, Technical and Economic Aspects of Vaccine Research and Development, in Pharmaceutical Biotechnology: Drug Discovery and Clinical Applications (eds O. Kayser and R. H. Müller), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, FRG. doi: 10.1002/3527602410.ch4

Editor Information

  1. Free University Berlin, Institute of Pharmacy, Pharmaceutical Technology, Biopharmacy & Biotechnology, Kelchstr. 31, 12169 Berlin, Germany

Author Information

  1. Chiron-Behring GmbH, Postfach 1630, 35006 Marburg, Germany

Publication History

  1. Published Online: 28 JAN 2005
  2. Published Print: 28 JAN 2004

ISBN Information

Print ISBN: 9783527305544

Online ISBN: 9783527602414

SEARCH

Keywords:

  • pharmaceutical biotechnology;
  • scientific aspects;
  • technical aspects;
  • economic aspects;
  • vaccine research;
  • vaccine development

Summary

  • Introduction

  • From the Research Concept to a Development Candidate

  • Vaccine Research Projects

  • Scientific Challenges of Vaccine R&D

  • Technical Aspects of Vaccine Development

    • Preclinical Development

    • Production Facilities

    • Clinical Development

    • Licensing and Registration of Vaccine Products

  • Economic Aspects of Vaccine Development

    • Vaccine Development Cost

    • Risks and Chances

  • Conclusion

  • References